Octapharma Research Site

Birmingham, Alabama 35233

1 studies enrolling now · 4 studies all time

What they study most

Adverse Effects in the Therapeutic Use of Plasma Substitutes, Cardiac Surgery, Coagulopathy, Liver Dysfunction, Liver Surgery, Pediatric Chronic Inflammatory Demyelinating Polyneuropathy, Primary Immune Deficiency Disorder

Studies at this site

• Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients — Recruiting now
• Study of Octanorm Subcutaneous IG in Patients With PID — Completed
• Octaplas Pediatric Plasma Replacement Trial — Completed
• Octaplas Pediatric Plasma Exchange Trial — Completed